USD 9.3 Billion
Report ID:
SQMIG35H2293 |
Region:
Global |
Published Date: November, 2024
Pages:
177
|Tables:
144
|Figures:
72
Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024–2031).
The use of bioreactors in the pharmaceutical sector is increasing driving bioreactors market growth. Bioreactors are vital for the development and improvement of various procedures due to which they are mostly used in pharmaceutical and biopharmaceutical research. Many industrial procedures also require bioreactors to use as subjects or for cultivating various organisms utilized for treating chronic illnesses. However, most pharmaceutical products use bioreactors in controlled conditions. Furthermore, the demand for monoclonal antibiotics is also increasing rapidly, contributing to the growth of the bioreactors market. Government bodies are also investing in funds along with private organizations to increase the production of various vaccines for different diseases. There is also subsequent demand for single-use bioreactors, which is also generating a large amount of revenue and expanding the bioreactors market. The pharma and biotechnology sectors are advancing and increasing, contributing to the growth of the bioreactors market. Technological innovation is also playing a vital part in the utilization of advanced bioreactors and different equipment of innovative features.
Global Market Size
USD 9.3 Billion
Largest Segment
Vaccines
Fastest Growth
Stem Cells
Growth Rate
12.58%
To get more reports on the above market click here to Buy The Report
Global Bioreactors Market is segmented by Materials, Scale, Usage, Application, Control Type, Suppliers, End-Users and region. Based on Materials, the market is segmented into Glass, Stainless Steel, Single-Use, and Others. Based on Scale, the market is segmented into 5L-20L, 20L-200L, 200L-1500L, and Above 1500L. Based on Application, the market is segmented into Antibodies, Vaccines, Cell Therapies, Others. Based on Usage, the market is segmented into Lab-Scale Production, Pilot-Scale Production, Full-Scale Production, and Others. Based on Control Type, the market is segmented into Manual, and Automated (MFCs). Based on Suppliers, the market is segmented into OEMs (Original Equipment Manufacturers), System Integrators, EPCs (Engineering Procurement and Construction). Based on End User, the market is segmented into R&D Institutes, Contract Research Organizations, Biopharmaceutical Manufacturers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Cell Type
Based on the cells, the bioreactors market is segmented into mammalian cells, yeast cells, and bacterial cells. The mammalian cells are dominating the market with the maximum revenue share. The growth of this segment is increasing because these cells are utilized in the commercial production and advancement of various vaccines and proteins. These products are utilized in many therapeutic procedures, contributing to the increasing demand for bioreactors market. Furthermore, viral analogs can also be produced with the help of mammalian cells. These are highly substantial for regenerative medicines and can be extremely useful in increasing the revenue size of bioreactors market. These factors are increasing the demand for mammalian cells in the bioreactors market.
The yeast cell segment is witnessing the fastest growth in the bioreactors market. This is mainly because yeasts are the most extensively utilized microorganisms in the manufacturing of a wide range of products. Furthermore, they are also the most used subject for research and development activities related to increasing their possible applications. One of the most popular applications of yeast cells is the manufacturing of fermented and protein-based items. Moreover, flocculation bioreactors are also gaining immense traction in water management, pharmaceutical, and food & beverage sector because of their high productivity, and cell density. These reactors are also majorly utilized in manufacturing procedures that need efficient flocculation management. These factors are increasing the growth of yeast cells in the bioreactors market.
Analysis by End Use
Based on end use the market is segmented into CROs, CMOs, pharma companies, and biopharmaceutical companies. The contract manufacturing organizations (CMOs) segment is dominating the bioreactors market. This is mainly due to the rising trend of outsourcing product development in the medical sector. These organizations are enabling manufacturers to establish a robust presence in emerging economies by introducing innovative products that can help them improve their medical offerings. This is also helping the companies to increase their market presence. Furthermore, CMOs also help companies that lack robust structure and technical skills. With this rising demand for outsourcing, CMOs are also increasing the adoption of bioreactors to accomplish better cost-efficiency. These factors are increasing the demand for CMOs in bioreactors, resulting in the growth of the market.
The biopharmaceutical companies are witnessing the fastest growth in the bioreactors market. This is primarily because innovative technologies are being adopted on a wider scale to streamline manufacturing procedures. This is increasing the demand for such products. The usage of bioreactors in manufacturing and advancing complex molecules such as proteins and nucleic acids are constantly increasing, contributing to the growth of the market. Furthermore, the increasing number of biotechnology companies are also increasing the demand for bioreactors. The medical sector is also embracing bioreactors and unique products for several medical procedures. These factors are increasing the growth and advancement for biopharmaceutical companies in the bioreactors market.
To get detailed analysis on other segments, Request For Free Sample Report
North America is dominating the bioreactors market with maximum market revenue. This dramatic surge in the market is mainly due to the presence of well-known manufacturers leading the market in the region. Moreover, there is also an increase in the number of patients suffering from chronic diseases along with the growth in geriatric population. These are increasing the demand for bioreactors in the market. Private and public facilities are also making massive investment in research and development activities for introducing new and advanced products, driving the growth of the market. The facilities offered for conducting research and development have advanced infrastructure to smoothen complex research activities. This research is also being supported by government as the demand for different types of vaccines have increased. These are propelling the growth of bioreactors market in North America.
The Asia Pacific region is witnessing substantial growth in the bioreactors market. This growth is mainly because this region is the hub for this growing biotechnological sector and some of the most popular companies. To increasing the growth of biotech and pharmaceutical markets in the regions, some of the key players are also extending their operations on developing economies such as India. For example, in January 20222, H.E.L Group, extended their operations in India with increasing focus on development of biotech sector. H.E.L. will introduce a unique regional hub that will provide local assistance to customers. It will support the country’s biotech and pharmaceutical markets. These factors are driving the adoption of bioreactors, contributing to the growth of the market.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Advancement of Preventive Vaccines
Increasing Rate of Organism Cultivation
Restraints
Increasing Ethical Problems
Reduced Capacity Bioreactors
Request Free Customization of this report to help us to meet your business objectives.
The bioreactor market is extremely competitive in nature due to the combination of prominent global and smaller and medium-sized companies. These organizations are all striving to increase their market share. Companies are also constantly focusing on innovations like automation and process control, integrated sensors and analytics, high-density cell cultures, and hybrid bioreactors. Furthermore, the market leaders are efficiently leading this dynamic setting with advancements through massive investments in research and development. Focus on strategic alliances, acquisitions, and mergers are also playing a vital part in the growth of the bioreactors market.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global bioreactors market growth is driven by the growing use in biopharmaceutical manufacturing. These solutions can help in the production of recombinant proteins, vaccines, fusion proteins, antibodies, enzymes, 3D tissues, and other biological items. The growth of the market is increasing due to the rising popularity of biologics in detecting diseases and clinical trials. They are available in various kinds, like hybrid technologies and materials like stainless steels. The key players who are helping in propelling the market growth are biopharmaceutical manufacturers and system integrators.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 1.35 million |
Market size value in 2031 | USD 2.68 million |
Growth Rate | 7.9% |
Base year | 2023 |
Forecast period | 2024–2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Bioreactors Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bioreactors Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bioreactors Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Bioreactors Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2293
sales@skyquestt.com
USA +1 351-333-4748